Successful clinical study for an innovative dengue vaccine, supervised by UNIL professor – News – CIVIS – Europe’s Civic University Alliance [Mergeți direct la conținut](#main) ![](https://civis.eu/build/assets/circle-05-Dj7Wr3Es.svg) ![](https://civis.eu/build/assets/circle-02-Dh7f4uYd.svg) ![](https://civis.eu/build/assets/circle-08-Bbt_UM7-.svg) [ ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg)](https://civis.eu/ro) - [ Descoperiți ](https://civis.eu/ro/discover-civis-alliance) - [ Ce este CIVIS? ](https://civis.eu/ro/discover-civis-alliance/what-is-civis) - [ Activitatea noastră ](https://civis.eu/ro/discover-civis-alliance/our-work) - [ Misiune, Viziune & Valori ](https://civis.eu/ro/discover-civis-alliance/our-institutional-journey) - [ Guvernanță și Management ](https://civis.eu/ro/discover-civis-alliance/governance-andamp-management) - [ Cine este cine? ](https://civis.eu/ro/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/ro/discover-civis-alliance/civis-association) [ Resurse ](https://civis.eu/ro/resources) - [ Învățare ](https://civis.eu/ro/learn) - [ Programe Intensive Mixte (BIPs) ](https://civis.eu/ro/learn/blended-intensive-programmes) - [ Învățare flexibilă ](https://civis.eu/ro/learn/build-your-learning-path-with-our-modular-offer) - [ Programe de Masterat ](https://civis.eu/ro/learn/find-your-master-s-programme) - [ Staff weeks & Job Shadowing ](https://civis.eu/ro/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Studiu în străinătate ](https://civis.eu/ro/learn/study-abroad-and-connect-with-civis-universities) [ TRACEE ](https://civis.eu/ro/the-civis-newsroom/tracee) [ CIVIS Museum University Forum ](https://civis.eu/ro/discover-civis-alliance/our-work/CIVIS-Museum-University-Forum) - [ Predare ](https://civis.eu/ro/teach) - [ Oportunități de predare ](https://civis.eu/ro/teach/civis-calls) - [ Inovați-vă predarea ](https://civis.eu/ro/teach/innovate-your-teaching) - [ Resurse pentru cadrele universitare ](https://civis.eu/ro/teach/resources-for-educators) [ CIVIS Invited to Begin Grant Agreement Preparations for New Erasmus+ Funding Phase ](https://civis.eu/ro/the-civis-newsroom/civis-invited-to-begin-grant-agreement-preparations-for-new-erasmus-funding-phase) [ Șapte ani de CIVIS: de la un proiect ambițios, la o comunitate academică în plină dezvoltare ](https://civis.eu/ro/the-civis-newsroom/seven-years-of-civis-from-an-ambitious-project-to-a-thriving-academic-community) - [ Cercetare ](https://civis.eu/ro/research) - [ Colaborări pentru cercetare ](https://civis.eu/ro/research/research-collaboration) - [ Cariere, Relații, Mobilități ](https://civis.eu/ro/research/research-careers-networks-and-projects) - [ Resurse pentru cercetători(-oare) ](https://civis.eu/ro/research/resources-for-researchers) [ CIVIS calls for strengthening Africa-Europe academic mobility through a visa policy for science partnerships ](https://civis.eu/ro/the-civis-newsroom/civis-calls-for-strengthening-africa-europe-academic-mobility-through-a-visa-policy-for-science-partnerships) [ CIVIS3i: Five Years Advancing Research Excellence Across CIVIS Alliance ](https://civis.eu/ro/the-civis-newsroom/civis3i-five-years-advancing-research-excellence-across-civis-alliance) - [ Conectați-vă ](https://civis.eu/ro/connect) - [ Buletine informative ](https://civis.eu/ro/connect/newsletters) - [ Zilele CIVIS ](https://civis.eu/ro/connect/civis-days) - [ Societate civilă ](https://civis.eu/ro/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Contactați-ne ](https://civis.eu/ro/contact) - [ Zona de presă și branding ](https://civis.eu/ro/connect/press-corner-branding-toolkit) [ CIVIS Student Ambassadors Take Centre Stage in Newsroom Pilot ](https://civis.eu/ro/the-civis-newsroom/civis-student-ambassadors-take-the-lead-inside-the-newsroom-pilot-project) [ Construind o alianță eficientă: cinci lecții învățate de la departamentele CIVIS ](https://civis.eu/ro/the-civis-newsroom/building-an-alliance-that-works-five-lessons-from-the-civis-units) [ Relatări ](https://civis.eu/ro/the-civis-newsroom) ro - [ en ](https://civis.eu/en/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ de ](https://civis.eu/de/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ fr ](https://civis.eu/fr/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ el ](https://civis.eu/el/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ it ](https://civis.eu/it/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ es ](https://civis.eu/es/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ sv ](https://civis.eu/sv/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) Menu - [Descoperiți](https://civis.eu/ro/discover-civis-alliance) [ Toggle submenu ](#primary-nav-sm-collapse-29) - [ Ce este CIVIS? ](https://civis.eu/ro/discover-civis-alliance/what-is-civis) - [ Activitatea noastră ](https://civis.eu/ro/discover-civis-alliance/our-work) - [ Misiune, Viziune & Valori ](https://civis.eu/ro/discover-civis-alliance/our-institutional-journey) - [ Guvernanță și Management ](https://civis.eu/ro/discover-civis-alliance/governance-andamp-management) - [ Cine este cine? ](https://civis.eu/ro/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/ro/discover-civis-alliance/civis-association) - [Învățare](https://civis.eu/ro/learn) [ Toggle submenu ](#primary-nav-sm-collapse-30) - [ Programe Intensive Mixte (BIPs) ](https://civis.eu/ro/learn/blended-intensive-programmes) - [ Învățare flexibilă ](https://civis.eu/ro/learn/build-your-learning-path-with-our-modular-offer) - [ Programe de Masterat ](https://civis.eu/ro/learn/find-your-master-s-programme) - [ Staff weeks & Job Shadowing ](https://civis.eu/ro/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Studiu în străinătate ](https://civis.eu/ro/learn/study-abroad-and-connect-with-civis-universities) - [Predare](https://civis.eu/ro/teach) [ Toggle submenu ](#primary-nav-sm-collapse-31) - [ Oportunități de predare ](https://civis.eu/ro/teach/civis-calls) - [ Inovați-vă predarea ](https://civis.eu/ro/teach/innovate-your-teaching) - [ Resurse pentru cadrele universitare ](https://civis.eu/ro/teach/resources-for-educators) - [Cercetare](https://civis.eu/ro/research) [ Toggle submenu ](#primary-nav-sm-collapse-32) - [ Colaborări pentru cercetare ](https://civis.eu/ro/research/research-collaboration) - [ Cariere, Relații, Mobilități ](https://civis.eu/ro/research/research-careers-networks-and-projects) - [ Resurse pentru cercetători(-oare) ](https://civis.eu/ro/research/resources-for-researchers) - [Conectați-vă](https://civis.eu/ro/connect) [ Toggle submenu ](#primary-nav-sm-collapse-33) - [ Buletine informative ](https://civis.eu/ro/connect/newsletters) - [ Zilele CIVIS ](https://civis.eu/ro/connect/civis-days) - [ Societate civilă ](https://civis.eu/ro/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Contactați-ne ](https://civis.eu/ro/contact) - [ Zona de presă și branding ](https://civis.eu/ro/connect/press-corner-branding-toolkit) [ Relatări ](https://civis.eu/ro/the-civis-newsroom) ro - [ en ](https://civis.eu/en/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ de ](https://civis.eu/de/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ fr ](https://civis.eu/fr/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ el ](https://civis.eu/el/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ it ](https://civis.eu/it/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ es ](https://civis.eu/es/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) - [ sv ](https://civis.eu/sv/the-civis-newsroom/successful-clinical-study-for-an-innovative-dengue-vaccine-supervised-by-unil-s-professor) 1. [Redacția CIVIS ](https://civis.eu/ro/the-civis-newsroom) 2. Successful clinical study for an innovative dengue vaccine, supervised by UNIL professor Successful clinical study for an innovative dengue vaccine, supervised by UNIL professor ======================================================================================== 16 februarie 2024 A new type of vaccine that induces cellular immunity to combat dengue fever has been the subject of a clinical study conducted by [Unisanté](https://www.unisante.ch/fr). The results, supervised by a professor from CIVIS member University UNIL, have just been published in the journal "*The Lancet eBioMedicine*" and encourage further investigation. This approach is also promising for other diseases. ![](/storage/files/header-stm-2022_2.png) stock photo by Canva​​​​​ A global health priority ------------------------ Global warming and urbanisation are facilitating the spread of the tiger mosquito, responsible for dengue fever. The World Health Oorganisation (WHO) estimates that almost half the world's population now lives in high-risk areas. Cases of dengue fever have increased eightfold in 20 years, leading to one hospitalisation per minute and two deaths per hour. Having **an effective vaccine is therefore a priority for global health**. Two dengue vaccines are currently available in Europe, but they are unsatisfactory in terms of safety and efficacy. Their technology is based on the production of antibodies which, in certain cases, can increase the severity of the disease when infected by the natural virus. Unisanté has evaluated the safety and immune response of a potential dengue vaccine (*PepGNP Dengue*), designed using an innovative technology to induce cellular immunity without stimulating antibody production. New approach and nano-innovations --------------------------------- The tested vaccine, PepGNP-Dengue, was developed in the UK by Emergex Vaccines. It consists of a nanodose of synthetic fragments of the virus fused to gold nanoparticles. Another special feature is that it is administered under the skin using a micro-needle. The vaccine relies on T lymphocytes, which are responsible for cellular immunity, to eliminate cells infected by the virus and prevent it from replicating. Emergex Vaccines chose Unisanté to carry out the clinical study in order to assess the safety of this vaccine, which is being administered to humans for the first time, given the institution's accumulated experience in evaluating vaccine candidates against Ebola and malaria in particular. The aim of phase 1 was to determine whether the vaccine did not induce severe undesirable side-effects in non-diseased volunteers. A total of 26 participants aged between 18 and 45 were vaccinated in Lausanne in 2021, and were followed for six months until March 2022. The results of this clinical study, supervised by Blaise Genton, Honorary Professor at UNIL, and coordinated by Dr Alix Miauton, Research Fellow at Unisanté, were published in January 2024 in The Lancet eBioMedicine. Positive results without adverse effects ---------------------------------------- During the trial, no serious adverse events related to the vaccine occurred. Local side effects (such as pain at the injection site) were the most frequently reported. Immunological results indicate that PepGNP-Dengue can stimulate a specific cellular response against the dengue virus without producing antibodies. These findings encourage further investigation into this innovative vaccine candidate and hold promise for other diseases where cellular immunity is important. A potential COVID-19 vaccine based on the same technology has also been tested by Unisanté on 26 participants, with results currently being published. **Dig into the [original story](https://news.unil.ch/display/1706104853462), in French.** Related news ------------ - [ ![](https://civis.eu/storage/files/laurent-audetat-800x600.jpg?token=1cc0b926783a2aab82f8c7ce4c5eb2b0)From Lausanne to Aix-Marseille: tracing research through the archives People 12 octombrie 2026 ](https://civis.eu/ro/the-civis-newsroom/from-lausanne-to-aix-marseille-tracing-research-through-the-archives) - [ ![](https://civis.eu/storage/files/brulau-800x600.jpg?token=a7e763ecd7ac25cced035c852cb8bc24)Scaling Collaboration – BruLau expands at CIVIS level Communication and Dissemination 25 august 2026 ](https://civis.eu/ro/the-civis-newsroom/scaling-collaboration-brulau-expands-at-civis-level) - [ ![](https://civis.eu/storage/files/fj3-800x600.jpg?token=0fdc7e0c89cf5d4d3998a334d3e3febd)Reclaiming (Feminist) Justice: three countries, three universities, one shared feminist memory CIVIS Highlights 8 iunie 2026 ](https://civis.eu/ro/the-civis-newsroom/reclaiming-feminist-justice-three-countries-three-universities-one-shared-feminist-memory) [ Descoperiți toate articolele noastre ](https://civis.eu/ro/the-civis-newsroom) [ Mission Europe pour la Recherche: towards a one-stop shop for European research funding ](%20https://civis.eu/ro/the-civis-newsroom/towards-a-one-stop-shop-to-apply-for-european-funding-launch-of-the-mission-europe-pour-la-recherche%20) [ Sustainable renovation of the Lubumbashi University Clinics proposed by ULB-UNILU students ](%20https://civis.eu/ro/the-civis-newsroom/ulb-unilu-student-microproject-a-sustainable-renovation-of-the-lubumbashi-university-clinics%20) ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg) ------------------------------------------------------------------------------------------------- Europe’s Civic University Alliance ![Co-funded by the European Union](https://civis.eu/build/assets/co-funded-by-the-european-union-DSKLW1us.png)Views and opinions expressed do not necessarily reflect those of the European Union or the European Education and Culture Executive Agency (EACEA). Neither can be held responsible for them. ### Persoane - [ Studenți ](https://civis.eu/ro/i-am-a-student) - [ Cadre universitare și cercetători ](https://civis.eu/ro/i-am-an-academic-researcher) - [ Personal administrativ ](https://civis.eu/ro/i-am-an-administrator) - [ Societate civilă ](https://civis.eu/ro/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Secțiune pentru presă și branding ](https://civis.eu/ro/connect/press-corner-branding-toolkit) ### Link-uri utile - [ Resurse ](https://civis.eu/ro/resources) - [ CIVIS Agora ](https://civis.eu/ro/civis-agora-the-operational-hub-of-the-civis-digital-campus) - [ European Universities initiative ](https://civis.eu/ro/european-universities-initiative) - [ Evenimente anterioare ](https://civis.eu/ro/past-events) - [ Contact ](https://civis.eu/ro/contact) [ Buletine informative ](https://civis.eu/ro/connect/newsletters) ### Social networks - [ ![](https://civis.eu/storage/files/instagram.svg) Instagram ](https://www.instagram.com/civis.eu/) - [ ![](https://civis.eu/storage/files/linkedin.svg) LinkedIn ](https://www.linkedin.com/company/civis-eu) - [ ![](https://civis.eu/storage/files/facebook.svg) Facebook ](https://www.facebook.com/CIVISEuropeanUniversity/) - [ ![](https://civis.eu/storage/files/youtube.svg) YouTube ](https://www.youtube.com/channel/UCdCm0FfreX81BuNH-znlRGQ) © 2026 – CIVIS – All rights reserved - [ Cookie Policy ](https://civis.eu/ro/cookie-policy) - [ Privacy policy ](https://civis.eu/ro/privacy-policy) Website by [Typi Design](https://typi.be) • Design by [Atelier Milky](https://ateliermilky.com) [ ](#top) Search